Altered CD27-related T cell subsets reflect immune imbalance in systemic lupus erythematosus
- PMID: 40381105
- DOI: 10.1007/s12026-025-09637-2
Altered CD27-related T cell subsets reflect immune imbalance in systemic lupus erythematosus
Abstract
Objective: This study aims to analyze CD27 expression in various subsets of CD4+ T cells in peripheral blood, explore the functional characteristics of the CD27+ subsets in regulatory T cells (Tregs) and CD4+ T cells, and assess their immunological alterations in newly diagnosed systemic lupus erythematosus (SLE) patients.
Methods: Peripheral blood was collected from 34 newly diagnosed, untreated SLE patients and 22 healthy controls. Flow cytometry was used to analyze CD27 expression on T cell subsets, comparing the functional markers between CD27+ and CD27- subsets. CD27 expression on Tregs and total CD4+ T cells in SLE patients and healthy controls were compared. ROC curves were constructed, and areas under the curve (AUCs) was calculated to evaluate the diagnostic value of CD27-related T cell subsets for SLE.
Results: The proportion of Tregs in the peripheral blood of SLE patients was increased, and CD27 expression was higher in Tregs than in CD4+ T cells in healthy individuals. CD27+ CD4+ T cells exhibited higher CD45RA and lower CD226 expression. CD27+ Tregs showed higher Helios and TIGIT expression and lower CD226 expression. CD27+ cell proportions in both CD4+ T cells and Tregs were significantly reduced in SLE patients. The AUC for CD27-related T cell subsets in diagnosing newly diagnosed SLE ranged from 0.6238 to 0.86.
Conclusion: CD27+ CD4+ T cells show reduced activation features, while CD27+ Tregs exhibit enhanced regulatory potential. Their decreased proportions in SLE patients suggest early immune dysregulation.
Keywords: CD27; CD4+ T cells; Regulatory T cells; Systemic lupus erythematosus.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Compliance with ethical standards. Competing interests: The authors declare no competing interests.
Similar articles
-
Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus.Immunol Res. 2017 Apr;65(2):551-563. doi: 10.1007/s12026-017-8904-4. Immunol Res. 2017. PMID: 28224362
-
Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.Int J Rheum Dis. 2016 Feb;19(2):199-204. doi: 10.1111/1756-185X.12451. Epub 2014 Oct 7. Int J Rheum Dis. 2016. PMID: 25293713
-
Reduced TRIM expression correlates with anomalous CD4 T cell activation in systemic lupus Erythematosus and its clinical diagnostic potential.Immunol Lett. 2024 Dec;270:106913. doi: 10.1016/j.imlet.2024.106913. Epub 2024 Sep 2. Immunol Lett. 2024. PMID: 39233252
-
The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.Front Immunol. 2019 Feb 18;10:159. doi: 10.3389/fimmu.2019.00159. eCollection 2019. Front Immunol. 2019. PMID: 30833946 Free PMC article.
-
Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.Arthritis Res Ther. 2010;12(1):101. doi: 10.1186/ar2894. Epub 2010 Jan 20. Arthritis Res Ther. 2010. PMID: 20122288 Free PMC article. Review.
References
-
- Ameer M, Chaudhry H, Mushtaq J, Khan OS, Babar M, et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus. 2022; https://doi.org/10.7759/cureus.30330 .
-
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12. https://doi.org/10.1002/art.40930 . - DOI - PubMed - PMC
-
- Baine I, Basu S, Ames R, Sellers RS, Macian F. Helios Induces Epigenetic Silencing of IL2 Gene Expression in Regulatory T Cells. J Immunol. 2013;190(3):1008–16. https://doi.org/10.4049/jimmunol.1200792 . - DOI - PubMed
-
- Basta F, Fasola F, Triantafyllias K, Schwarting A. Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New. Rheumatol Ther. 2020;7(3):433–46. https://doi.org/10.1007/s40744-020-00212-9 . - DOI - PubMed - PMC
-
- Buchan SL, Rogel A, Al-Shamkhani A. The Immunobiology of CD27 and OX40 and Their Potential as Targets for Cancer Immunotherapy. Blood. 2018;131(1):39–48. https://doi.org/10.1182/blood-2017-07-741025 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials